India Orders Sun Pharma to Halt Eye-Care Drug Production at Assam Plant

Indian drug regulators ordered Sun Pharmaceutical Industries to stop manufacturing, selling and distributing ophthalmic products made at its Assam facility after finding failures in its quality management system, Reuters reported.